By then the surgeon Sampson, working with Darell Bigner, had devised a similar vaccine, and he began testing it in several small trials starting in 2002.
It takes aim at an unusual mutation discovered in the late 1980s by Albert Wong and Bert Vogelstein at Johns Hopkins University and Darell Bigner at Duke.